{"id":395461,"date":"2026-03-20T19:10:08","date_gmt":"2026-03-20T19:10:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/395461\/"},"modified":"2026-03-20T19:10:08","modified_gmt":"2026-03-20T19:10:08","slug":"abbott-closing-exact-sciences-acquisition-next-week-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/395461\/","title":{"rendered":"Abbott closing Exact Sciences acquisition next week | News"},"content":{"rendered":"<p>MADISON, Wis. &#8212; Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.<\/p>\n<p>Madison-based Exact Sciences is known for its cancer detection technology such as Cologuard. Abbott announced last year that it would buy the company for $23 billion.<\/p>\n<p>&#8220;The addition of Exact Sciences enhances Abbott&#8217;s growth profile and strengthens our leadership in diagnostics,&#8221; Abbott chairman and CEO Robert Ford said in a statement on Friday. &#8220;This transaction brings a powerful new platform in cancer screening and diagnostics into Abbott, advancing our mission to make care more accessible and give people more control over their health.&#8221;<\/p>\n<p>Abbott said Friday that it had received all regulatory clearances for the acquisition.<\/p>\n<p>Originally founded in Massachusetts in 1995, Exact Sciences made the move to Madison in 2009.<\/p>\n<p>\u200bCOPYRIGHT 2026 BY CHANNEL 3000. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.<\/p>\n","protected":false},"excerpt":{"rendered":"MADISON, Wis. &#8212; Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.&hellip;\n","protected":false},"author":2,"featured_media":395462,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[77782,4781,110,180083,180084,18,103558,180082,135,475,474,19,17],"class_list":{"0":"post-395461","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-abbott","9":"tag-abbott-laboratories","10":"tag-cancer","11":"tag-cancer-detection-technology","12":"tag-cologuard","13":"tag-eire","14":"tag-exact-sciences","15":"tag-exact-sciences-corporation","16":"tag-health","17":"tag-health-care","18":"tag-healthcare","19":"tag-ie","20":"tag-ireland"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116263087310038906","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/395461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=395461"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/395461\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/395462"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=395461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=395461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=395461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}